MedTrace Logo

Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

NCT02120066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2014-04-22

No results posted yet for this study

Summary

Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.

Conditions

  • Submacular Hemorrhage
  • Ruptured Retinal Arterial Macro Aneurysms

Interventions

PROCEDURE

Vitrectomy for submacular hemorrhage

DRUG

subretinal injection of tissue-plasminogen activator

Sponsors & Collaborators

  • Kyorin University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-06-30
Completion
2014-04-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02120066 on ClinicalTrials.gov